MX2022010928A - Ácido nucleico de cadena larga, completamente sintético para la producción de vacunas para protección contra coronavirus. - Google Patents
Ácido nucleico de cadena larga, completamente sintético para la producción de vacunas para protección contra coronavirus.Info
- Publication number
- MX2022010928A MX2022010928A MX2022010928A MX2022010928A MX2022010928A MX 2022010928 A MX2022010928 A MX 2022010928A MX 2022010928 A MX2022010928 A MX 2022010928A MX 2022010928 A MX2022010928 A MX 2022010928A MX 2022010928 A MX2022010928 A MX 2022010928A
- Authority
- MX
- Mexico
- Prior art keywords
- nucleic acid
- long
- protect against
- chain nucleic
- fully synthetic
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 102000039446 nucleic acids Human genes 0.000 title abstract 2
- 108020004707 nucleic acids Proteins 0.000 title abstract 2
- 150000007523 nucleic acids Chemical class 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 241000711573 Coronaviridae Species 0.000 title 1
- 208000025721 COVID-19 Diseases 0.000 abstract 1
- 241001678559 COVID-19 virus Species 0.000 abstract 1
- 241000008910 Severe acute respiratory syndrome-related coronavirus Species 0.000 abstract 1
- 108010003533 Viral Envelope Proteins Proteins 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20051—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Esta invención describe un ácido nucleico de cadena larga, completamente sintético que se puede utilizar en procesos de fabricación biotecnológica para producir proteínas de envoltura, envolturas de virus y fragmentos de envolturas de virus de SARS-CoV-2 y coronavirus relacionados en una forma altamente purificada, los cuales, como una vacuna protegen contra el COVID-19 y otras enfermedades virales.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20020092 | 2020-03-03 | ||
| EP20020240 | 2020-05-20 | ||
| PCT/EP2021/055401 WO2021175960A1 (en) | 2020-03-03 | 2021-03-03 | Fully synthetic, long-chain nucleic acid for vaccine production to protect against coronaviruses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2022010928A true MX2022010928A (es) | 2022-10-27 |
Family
ID=83450836
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2022010928A MX2022010928A (es) | 2020-03-03 | 2021-03-03 | Ácido nucleico de cadena larga, completamente sintético para la producción de vacunas para protección contra coronavirus. |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP4114452A1 (es) |
| JP (1) | JP2023517540A (es) |
| KR (1) | KR20220150323A (es) |
| CN (1) | CN115768470A (es) |
| AU (1) | AU2021231238A1 (es) |
| BR (1) | BR112022017733A2 (es) |
| CA (1) | CA3170281A1 (es) |
| IL (1) | IL296147A (es) |
| MX (1) | MX2022010928A (es) |
-
2021
- 2021-03-03 JP JP2022553056A patent/JP2023517540A/ja active Pending
- 2021-03-03 CN CN202180032734.6A patent/CN115768470A/zh active Pending
- 2021-03-03 CA CA3170281A patent/CA3170281A1/en active Pending
- 2021-03-03 IL IL296147A patent/IL296147A/en unknown
- 2021-03-03 AU AU2021231238A patent/AU2021231238A1/en active Pending
- 2021-03-03 KR KR1020227033430A patent/KR20220150323A/ko active Search and Examination
- 2021-03-03 BR BR112022017733A patent/BR112022017733A2/pt unknown
- 2021-03-03 EP EP21709001.8A patent/EP4114452A1/en active Pending
- 2021-03-03 MX MX2022010928A patent/MX2022010928A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA3170281A1 (en) | 2021-09-10 |
| IL296147A (en) | 2022-11-01 |
| AU2021231238A1 (en) | 2022-10-06 |
| BR112022017733A2 (pt) | 2022-11-29 |
| KR20220150323A (ko) | 2022-11-10 |
| JP2023517540A (ja) | 2023-04-26 |
| CN115768470A (zh) | 2023-03-07 |
| EP4114452A1 (en) | 2023-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2021155243A8 (en) | Respiratory virus immunizing compositions | |
| BRPI0922867B8 (pt) | glicoproteina de fusão (f) de vírus sincicial respiratório (rsv), ácido nucleico isolado, célula hospedeira, composição de vacina e micela purificada | |
| CY1121159T1 (el) | Μη-ενσωματουμενοι λεντiϊικοι φορεις | |
| BR112016007868A2 (pt) | vacinas contra o vírus de epstein-barr | |
| CY1121377T1 (el) | Θεραπευτικα εμβολια hpv16 | |
| WO2016037154A8 (en) | Recombinant hiv-1 envelope proteins and their use | |
| EP2765138A3 (en) | HIV-1 envelope glycoprotein | |
| BR112018011122A2 (pt) | antígenos, vetores, composições, e métodos de utilização para o vírus da imunodeficiência humana dos mesmos | |
| CY1118856T1 (el) | Εμβολιο pcsk9 | |
| EA201692359A1 (ru) | Композиция на основе нового штамма prrsv или его белков, продукт, их применение, вирус prrsv, выделенная нк и рекомбинантный вектор экспрессии для получения этого вируса | |
| AR081809A1 (es) | Composiciones farmaceuticas que comprenden un polipeptido que comprende al menos un motivo cxxc y antigenos heterologos y usos de las mismas | |
| IN2014DN10288A (es) | ||
| MX2022010588A (es) | Vacuna basada en poxvirus recombinantes contra el virus sars-cov-2. | |
| PH12016500500A1 (en) | A viral vaccine and methods of manufacture thereof | |
| MX2018010483A (es) | Inmunogenos para vacunacion contra vih. | |
| PH12020552252A1 (en) | Influenza virus hemagglutinin mutants | |
| WO2020035609A3 (en) | Immunogenic compositions and uses thereof | |
| CL2018000164A1 (es) | Vector recombinante del virus orf. | |
| MA37749B1 (fr) | Vaccins contre les virus réassortis de la fièvre catarrhale et de la peste équine | |
| MX2022010928A (es) | Ácido nucleico de cadena larga, completamente sintético para la producción de vacunas para protección contra coronavirus. | |
| MX2023013004A (es) | Composicion inmunogenica contra la influenza. | |
| MX2023007319A (es) | Vacunas de acido nucleico. | |
| BR112018003580A2 (pt) | molécula de ácido nucléico, método para apresentar um polipeptídeo alvo, proteína recombinante, partícula do tipo viral, composição farmacêutica, polipeptídeo, vetor, célula hospedeira e método para preparar a proteína recombinante | |
| EP3069730A3 (en) | Soluble hiv-1 envelope glycoprotein trimers | |
| MX2018009676A (es) | Proceso. |